BWAY
Price
$12.48
Change
-$0.12 (-0.95%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
530.97M
47 days until earnings call
Intraday BUY SELL Signals
ECOR
Price
$10.14
Change
-$0.17 (-1.65%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
99.45M
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BWAY vs ECOR

BWAY vs ECOR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BWAY vs. ECOR commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BWAY is a StrongBuy and ECOR is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
BWAY vs ECOR: Fundamental Ratings
BWAY
ECOR
OUTLOOK RATING
1..100
1885
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
58100
SMR RATING
1..100
61100
PRICE GROWTH RATING
1..100
4836
P/E GROWTH RATING
1..100
33100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ECOR's Valuation (59) in the Medical Specialties industry is in the same range as BWAY (80). This means that ECOR’s stock grew similarly to BWAY’s over the last 12 months.

BWAY's Profit vs Risk Rating (58) in the Medical Specialties industry is somewhat better than the same rating for ECOR (100). This means that BWAY’s stock grew somewhat faster than ECOR’s over the last 12 months.

BWAY's SMR Rating (61) in the Medical Specialties industry is somewhat better than the same rating for ECOR (100). This means that BWAY’s stock grew somewhat faster than ECOR’s over the last 12 months.

ECOR's Price Growth Rating (36) in the Medical Specialties industry is in the same range as BWAY (48). This means that ECOR’s stock grew similarly to BWAY’s over the last 12 months.

BWAY's P/E Growth Rating (33) in the Medical Specialties industry is significantly better than the same rating for ECOR (100). This means that BWAY’s stock grew significantly faster than ECOR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BWAYECOR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 15 days ago
84%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
79%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (BWAY: $12.60 vs. ECOR: $10.31)
Brand notoriety: BWAY and ECOR are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BWAY: 141% vs. ECOR: 142%
Market capitalization -- BWAY: $530.97M vs. ECOR: $99.45M
BWAY [@Medical/Nursing Services] is valued at $530.97M. ECOR’s [@Medical/Nursing Services] market capitalization is $99.45M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $174.73B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BWAY’s FA Score shows that 1 FA rating(s) are green while ECOR’s FA Score has 0 green FA rating(s).

  • BWAY’s FA Score: 1 green, 4 red.
  • ECOR’s FA Score: 0 green, 5 red.
According to our system of comparison, BWAY is a better buy in the long-term than ECOR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BWAY’s TA Score shows that 4 TA indicator(s) are bullish while ECOR’s TA Score has 3 bullish TA indicator(s).

  • BWAY’s TA Score: 4 bullish, 5 bearish.
  • ECOR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BWAY is a better buy in the short-term than ECOR.

Price Growth

BWAY (@Medical/Nursing Services) experienced а -4.62% price change this week, while ECOR (@Medical/Nursing Services) price change was -9.12% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.15%. For the same industry, the average monthly price growth was -6.04%, and the average quarterly price growth was -2.68%.

Reported Earning Dates

BWAY is expected to report earnings on Nov 18, 2026.

ECOR is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Medical/Nursing Services (-2.15% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
BWAY
Daily Signal:
Gain/Loss:
ECOR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PSTP37.470.02
+0.05%
Innovator Power Buffer Step-Up Strategy ETF (PSTP)
AGGS38.97-0.02
-0.05%
Harbor Disciplined Bond ETF (AGGS)
RTYY7.86-0.04
-0.46%
GraniteShares YieldBoost RIOT ETF (RTYY)
GQRE58.93-0.52
-0.88%
Northern Trust Global Quality Real Estate ETF (GQRE)
CGIE36.29-0.42
-1.13%
Capital Group International Equity ETF (CGIE)

BWAY and

Correlation & Price change

A.I.dvisor tells us that BWAY and DCTH have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BWAY and DCTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BWAY
1D Price
Change %
BWAY100%
-4.55%
DCTH - BWAY
33%
Poorly correlated
-3.51%
ISRG - BWAY
31%
Poorly correlated
-1.33%
QSI - BWAY
31%
Poorly correlated
+33.64%
MBOT - BWAY
31%
Poorly correlated
N/A
ITGR - BWAY
28%
Poorly correlated
+0.06%
More

ECOR and

Correlation & Price change

A.I.dvisor tells us that ECOR and QDEL have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ECOR and QDEL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ECOR
1D Price
Change %
ECOR100%
-4.67%
QDEL - ECOR
29%
Poorly correlated
-1.52%
SENS - ECOR
28%
Poorly correlated
-2.06%
PFSA - ECOR
28%
Poorly correlated
-5.56%
AXGN - ECOR
26%
Poorly correlated
-4.77%
BWAY - ECOR
26%
Poorly correlated
-4.55%
More